Skinvisible, Inc. (SKVI)
OTCMKTS · Delayed Price · Currency is USD
0.1700
-0.0320 (-15.84%)
At close: May 7, 2026
Skinvisible Employees
Skinvisible had 2 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$10,000
Profits / Employee
-$532,017
Market Cap
918.65K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2024 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2023 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2022 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2021 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Skinvisible News
- 8 months ago - Ovation Science and Skinvisible Pharmaceuticals Enhance Their Strategic Partnership in the Obesity Market with Innovative Cannabinoid Delivery Technology with New Developments and Patent Protection - Accesswire
- 1 year ago - Skinvisible Reports Licensee Success in Netherton Syndrome Clinical Studies - Accesswire
- 1 year ago - Skinvisible announces article on transdermal obesity formulation development - TheFly
- 1 year ago - Skinvisible Announces Article Highlighting Its Proprietary Transdermal Obesity Formulation Development - Accesswire
- 1 year ago - Promising Data on Transdermal Obesity Formulations Announced by Skinvisible - Accesswire
- 1 year ago - Skinvisible Inc unveils data on transdermal obesity formulations - TheFly
- 2 years ago - Skinvisible Inc expands obesity patent application for transdermal delivery - TheFly
- 2 years ago - Skinvisible Expands Obesity Patent Application for Transdermal Delivery - Accesswire